Stablecoin Development Corp (B9P1) AI Stock Analysis
Stablecoin Development Corp
(Frankfurt:B9P1)
No summary available
Stablecoin Development Corp (B9P1) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 50.59M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 0.1
- Beta (1Y)
- 2.73
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- 4
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management - Cryptocurrency
Stablecoin Development Corp Business Overview & Revenue Model
Company Description
Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralize...
Stablecoin Development Corp Earnings Call Summary
The earnings call presented a mixed outlook, with strong growth and efficiency improvements in the eyecare segment, but challenges in overall revenue and net loss due to declines in wound care sales and low cash reserves.
Q2-2024 Updates
Positive Updates
Negative Updates
Company Guidance
During the NovaBay Pharmaceuticals Q2 2024 earnings call, the company reported a strong performance in its eyecare segment, with sales of eyecare products reaching $4.8 million for the first half of the year. They are on track to meet their annual target of $10 million in eyecare sales. The company has successfully reduced sales and marketing expenses by 13% year-over-year while achieving an 8% increase in eyecare revenue for Q2 2024, primarily through online OTC channels. Subscribe & Save customers on Amazon, their largest sales channel, grew by 16% in the first half of 2024, contributing to approximately 24% of online Avenova revenue. The gross margin improved to 66% in Q2 2024 from 49% in the prior year due to a shift towards higher-margin eyecare products. NovaBay's strategic focus remains on efficient growth within the U.S. dry eye market, anticipated to exceed $4.8 billion by 2030.
Stablecoin Development Corp Risk Analysis
Stablecoin Development Corp disclosed 54 risk factors in its most recent earnings report. Stablecoin Development Corp reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksStablecoin Development Corp Peers Comparison
Overall Rating
CIRC37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 37Underperform | $34.19M | -0.14 | 2206.07% | ― | 27.45% | 82.80% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:B9P1 | Stablecoin Development Corporation | 2.20 | -19.50 | -89.86% | |
| CIRC | Circle8 Group, Inc. | 0.29 | -2.34 | -88.94% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.